HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Problems related to infarct size measurements in the rat heart.

Abstract
The feasibility of measuring the extent of hypoperfused myocardium and the infarct size was examined in rat hearts after occlusion of the left coronary artery. The extent of hypoperfused myocardium was examined by autoradiography and after perfusion with fluorescent microspheres. Both methods appeared unreliable in this model. Triphenyltetrazolium chloride (TTC) staining, however, provided a distinct demarcation line between viable myocardium, which was stained red, and the necrotic myocardium, consistent with the ultrastructural border between normal and severely damaged myocytes 5 h after coronary occlusion. TTC staining gives the best demarcation of ischemic tissues. In verapamil-treated rats, there was an apparent reduction in infarct size as compared with untreated rats; 20% reduction in infarct size 5 h after coronary occlusion and 12% reduction after 24 h. There was, however, a large postoperative mortality among the verapamil-treated rats. These problems, and the nonuniform infarct size in rats, may in part explain why infarct size limitation by verapamil has been reported from rat experiments, but not from clinical trials.
AuthorsG Greve, T Saetersdal
JournalActa anatomica (Acta Anat (Basel)) Vol. 142 Issue 4 Pg. 366-73 ( 1991) ISSN: 0001-5180 [Print] Switzerland
PMID1724868 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tetrazolium Salts
  • triphenyltetrazolium
  • Verapamil
Topics
  • Animals
  • Autoradiography
  • Female
  • Fluorescence
  • Heart (drug effects)
  • Microscopy, Electron
  • Microspheres
  • Myocardial Infarction (pathology)
  • Myocardium (pathology, ultrastructure)
  • Rats
  • Rats, Inbred Strains
  • Staining and Labeling (methods)
  • Tetrazolium Salts
  • Verapamil (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: